Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity

Tianyi Liu1,2, Meng Zhang1,2, Tatyanah Farsh1,2

  • 1University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, 94158, USA.

PubMed

Insights

Autophagy gene ATG9A regulates cancer cell defense against macrophage killing. Inhibiting ATG9A enhances cancer cell sensitivity to macrophage-mediated death, improving anti-tumor immunity when combined with CSF1R inhibitors.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Biology

Background:

  • Macrophages are key immune cells in tumors, influencing cancer cell survival or death.
  • Macrophage-mediated cytotoxicity is crucial for anti-tumor immunity, but its regulators are not fully understood.

Purpose of the Study:

  • To identify regulators of macrophage cytotoxicity against cancer cells.
  • To explore therapeutic strategies combining macrophage-based therapies with tumor intrinsic mechanisms.

Main Methods:

  • Utilized CRISPR screens in co-culture systems with CAR-macrophages.
  • Performed in vitro and in vivo experiments with ATG9A-depleted cancer cells.
  • Conducted proteomic and lipidomic analyses.
  • Investigated combined therapies involving CSF1R inhibition and ATG9A modulation in mouse models.

Main Results:

  • Autophagy gene ATG9A was identified as a critical regulator of cancer cell resistance to macrophage killing.
  • ATG9A deficiency in cancer cells sensitized them to macrophage-induced death.
  • ATG9A deficiency impaired cancer cell membrane repair mechanisms, including lysosomal exocytosis, ceramide production, and caveolar endocytosis.
  • Combined inhibition of CSF1R (to enrich cytotoxic macrophages) and ATG9A-mediated tumor membrane repair enhanced anti-tumor antibody efficacy in mice.

Conclusions:

  • Macrophage cytotoxicity is vital for tumor elimination in CAR-macrophage and antibody-based therapies.
  • Targeting ATG9A to impair tumor membrane repair, especially when combined with strategies that enhance cytotoxic macrophage populations, can significantly improve the efficacy of cancer immunotherapies.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.4K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
73.7K
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.4K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K